---
figid: PMC7509716__ADVS-7-2000771-g007
figtitle: Proposed mechanism for enhancing antigen‐specific immune response by the
  CS‐IONzyme‐based influenza vaccine
organisms:
- unidentified influenza virus
- H1N1 subtype
- H5N6 subtype
- Homo sapiens
- Mus musculus
- Armoracia rusticana
- Salmonella enterica subsp. enterica serovar Typhimurium
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7509716
filename: ADVS-7-2000771-g007.jpg
figlink: pmc/articles/PMC7509716/figure/advs1948-fig-0007/
number: SF1
caption: Schematic of proposed mechanism for enhancing antigen‐specific immune response
  by the CS‐IONzyme‐based influenza vaccine. CS‐IONzyme first enhances the adhesion
  levels of H1N1 WIV to nasal mucosa after intranasal immunization of CS‐IONzyme‐based
  influenza vaccine in mice. Next, CS‐IONzyme strongly stimulates nasal epithelial
  cells (ECs) to secrete chemokine CCL20 via toll‐like receptor (TLR) 2/4 pathway,
  which recruits more DCs into the submucosal regions to form transepithelial dendrites
  (TEDs) for H1N1 WIV uptake. After viral capture, DCs gradually reach the phenotypic
  and functional maturation and then quickly migrate into draining cervical lymph
  nodes (CLNs) for antigen presentation. Finally, the antigen‐specific immune response
  is initiated.
papertitle: Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant.
reftext: Tao Qin, et al. Adv Sci (Weinh). 2020 Sep;7(18):2000771.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9012171
figid_alias: PMC7509716__SF1
figtype: Supplemental figure
redirect_from: /figures/PMC7509716__SF1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7509716__ADVS-7-2000771-g007.html
  '@type': Dataset
  description: Schematic of proposed mechanism for enhancing antigen‐specific immune
    response by the CS‐IONzyme‐based influenza vaccine. CS‐IONzyme first enhances
    the adhesion levels of H1N1 WIV to nasal mucosa after intranasal immunization
    of CS‐IONzyme‐based influenza vaccine in mice. Next, CS‐IONzyme strongly stimulates
    nasal epithelial cells (ECs) to secrete chemokine CCL20 via toll‐like receptor
    (TLR) 2/4 pathway, which recruits more DCs into the submucosal regions to form
    transepithelial dendrites (TEDs) for H1N1 WIV uptake. After viral capture, DCs
    gradually reach the phenotypic and functional maturation and then quickly migrate
    into draining cervical lymph nodes (CLNs) for antigen presentation. Finally, the
    antigen‐specific immune response is initiated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ecs
  - Jun
  - H2
  - Cd40
  - Cd80
  - Cd86
  - Tnf
  - Il16
  - Il6
  - Il10
  - Clgn
  - Igh-V7183
  - Igh-VS107
  - Ighv1-62
  - Cd79a
  - Igha
  - JUN
  - JUNB
  - JUND
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL2
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - CXCL9
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - CD40
  - CD80
  - CD86
  - TNF
  - IL16
  - IL6
  - IL10
  - CD79A
  - jun
  - mhc2dga
  - mhc2dgb
  - si:busm1-194e12.7
  - si:busm1-194e12.8
  - si:busm1-266f07.2
  - cd40
  - tnfb
  - il16
  - il6
  - il10
---
